Bon Natural Life Limited announces the full exercise of the lead manager's over-allotment option

Xian, China, July 02, 2021 (GLOBE NEWSWIRE) – Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of organic ingredients to the nature, health and body sectors Care Industries, today announced the issue and sale of an additional 330,000 shares of common stock with a par value of $ 0.0001 per share (the “Shares”) at a public offering price of $ 5.00 per share, resulting in a additional gross proceeds of $ 1,650,000 before subscription haircuts and commissions and issuing expenses due to the full exercise of the underwriters’ over-allotment option in connection with BON’s previously announced public offering. The offer was carried out on the basis of a firm commitment.

After the underwriting banks fully exercised their over-allotment option, the total number of shares sold by BON in the IPO was 2,530,000 shares and total gross proceeds of $ 12,650,000, before subscription discounts, commissions and offering costs. The stock was traded on June 24, 2021 under the symbol “BON” on the Nasdaq Capital Market.

US Tiger Securities, Inc. and Newbridge Securities Corporation acted as co-lead book running managers, RF Lafferty & Co. Inc. acted as joint lead book running managers, and Ascendant Global Advisors acted as financial advisor to the company. The Crone Law Group served as US Securities Counsel to the company, and Ellenoff Grossman & Schole LLP served as counsel to the underwriters.

Registration statements on Form F-1 (File Numbers 333-251182 and 333-257328) relating to the offering have been filed with the Securities and Exchange Commission (“SEC”), which have been declared effective by the SEC and effective upon filing on June January 23, 2021. The offer is made exclusively by means of a prospectus, which is part of the registration declaration. Copies of the prospectus for the offering are available on the SEC’s website at

The story goes on

This press release does not constitute an offer to sell or an invitation to buy, nor may any sale of these securities be made in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification the securities laws of any such state or jurisdiction.

over Bon Natural Life Limited

The company focuses on the manufacture of personal care ingredients such as herbal extracted fragrances for perfume and fragrance manufacturers, natural nutritional supplements such as powdered beverages and bioactive food ingredients, which are mainly used by their customers as food additives and nutritional supplements. For more information, please visit the company’s website at

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements about plans, goals, objectives, strategies, future events or performance, and underlying assumptions and other statements that are not statements of historical fact. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that are not limited to As history relates matters, it makes forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual results to differ materially from the company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to: the company’s goals and strategies; the future business development of the company; Demand and acceptance of products and services; Changes in technology; Economic situation; the growth of the natural, health and personal care markets in China and the other international markets the company plans to serve; Reputation and brand; the effects of competition and pricing; state restrictions; Fluctuations in general economic conditions in China and the international markets that the company intends to serve, as well as assumptions underlying or related to the foregoing, and other risks contained in reports the company has filed with the SEC submitted. For these reasons, among others, investors are cautioned not to place undue reliance on any forward-looking statements in this press release. Additional factors are discussed in the company’s filings with the SEC, which can be found at The company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that occur after the date of this release.

For more information, please contact: